FUBP3 and chronic myelogenous leukemia, BCR-ABL1 positive: Collectively, the findings of this study imply that FUBP3 protein, together with PRC2 complex, regulates PAK1 expression that consecutively leads to an increase in ERK expression, which conduces towards disease progression and loss of response in CML (Figure 6L).